跳至主要内容
临床试验/ISRCTN34762792
ISRCTN34762792已完成未知

Evaluation of the impact of fermented milk containing Lactobacillus casei strain Shirota (LcS) on stool consistency

Yakult Honsha European Research Centre for Microbiology ESV0 个研究点目标入组 64 人开始时间: 2019年6月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
64

研究概览

简要总结

2024 Results article in https://doi.org/10.3390/nu16152469 (added 01/08/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Informed consent obtained before any study-related activities
  • 2. Healthy female or male aged 18–65 years (inclusive)
  • 3. Produces hard stool (BS1 and 2 stools), with a frequency of 50% or more during 2 weeks of screening data period
  • 4. Does not take probiotics 2 weeks before the start of screening data collection. If the patient takes probiotics, a washout period of 2 weeks is needed
  • 5. Is willing and able to collect every stool at home during 3 consecutive days and this 3 times during the treatment period, to store the samples in appropriate conditions and to return the samples within the required timeframe
  • 6. Is willing and able to complete a diary during the screening, baseline and treatment period in order to collect information about the form of the stools (based on the Bristol Stool Form Scale classification) and bowel habit
  • 7. Prepared not to change the current drinking, eating, smoking and exercising habits during the course of the study
  • 8. Understands the Dutch or English language (reading, writing, speaking)

排除标准

  • 1. Language barrier, mental or legal incapacity, unwillingness or inability to understand or not being able to participate in the study
  • 2. Is vegetarian or vegan
  • 3. Is treated (i.e., currently treated, treated within 1 month before screening) by a doctor for her/his constipation
  • 4. Has any history of gastrointestinal surgery except for appendectomy
  • 5. Has any history of chronic/severe gastrointestinal disorders
  • 6. Females of childbearing potential who are pregnant, breastfeeding or intend to become pregnant or are not using adequate contraceptive methods (e.g., oral contraceptive, condom, intrauterine device, abstinence)
  • 7. Is unable to refrain from or anticipates the use of antibiotics and/or laxatives
  • 8. Has any history of drug and/or alcohol abuse
  • 9. Has milk allergies
  • 10. Is intolerant to lactose
  • 11. Any clinically significant disease which in the Investigator’s opinion could interfere with the safety of study participants or with the results of the study
  • 12. Use of disallowed concomitant medications and concomitant products within 2 weeks before the screening period, depending if a wash out period for probiotics is needed
  • 13. Cancer (past or present, except basal cell skin cancer or squamous cell skin cancer), which in the Investigator’s opinion could interfere with the results of the study
  • 14. Previous participation in this study. Participation is defined as screened. Re-screening is therefore not allowed
  • 15. Participation in another interventional clinical study or receipt of any investigational product within 1 month before the screening period

研究者

发起方
Yakult Honsha European Research Centre for Microbiology ESV

相似试验